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PERSPECTIVES AND SUMMARY
Excitable membranes are the carriers of electrical signal transmission in
biology. Well-known examples of excitable biomembranes are the plasma
membranes of nerve and muscle cells. Excitability of these cells is generally
manifested in rapid transient changes (msec time range) of electrical proper-
ties. Nerve impulse and other membrane potential changes and the concom-
itant ionic crossmembrane currents result from changes in. the electrical
conductivity of the membrane. These conductivity changes reflect mem-
brane permeability changes, in many cases selectively to Na+, K+, Ca2+, or
117
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118 NEUMANN & BERNHARDT
CI- ions. The permeability changes mobilizing the metabolically maintained
steady-state gradients of these ions can be brought about by physical and
chemical changes in the membrane and the immediate environment.
The electrical properties of excitable biomembranes have been explored
intensively and neurochemical investigations gain increasingly in interest.
Yet, the major unsolved problem ofbioelectricity is the molecular mechanism
underlying the permeability changes in excitable biomembranes. We are
thus faced with mechanistic questions that require biochemical techniques
for the isolation and identification of permeability control systems, and
physical-chemical methods for the molecular characterization of the regula-
tory apparatus and its components. At present this aim is yet a largely
programmatic perspective. The problems cover a multidisciplinary field and
require an integration of many results of various disciplines. In a situation
where little is known about the nature of the observed bioelectrical phenom-
ena, theoretical approaches are very useful as working hypotheses, provided
they are general, and yet specific enough to differentiate between various
alternatives, and stimulate and guide new experiments. Recent evidence
shows that newer voltage-clamp data cannot be described with conventional ¯
model theories such as the Hodgkin-Huxley formalism. Very probably, only
dissipative chemical models are adequate for the correlation between mea-
sured conductivity changes and intrinsic membrane permeability parame-
ters.
A molecular interpretation requires chemical information on the compo-
nents of the control systems. Several components of permeation regulation
systems have been isolated and thermodynamic and kinetic properties have
been measured. In a few cases comparison of physical-chemical properties
between isolated macromolecules and the membrane-bound in vivo system
is very suggestive. Yet the number values given have to be seen in the
framework of the assumptions underlying the theoretical approaches. Most
intensive physical-chemical investigations have been performed with the
isolated and membrane-bound acetylcholine receptor; attempts to recom-
bine this regulatory protein with artificial lipid membrane are just begin-
ning. Therefore, the thermodynamic and kinetic properties of this control
component are discussed in detail.
This review is necessarily limited to those studies in which physical-
chemical methods were applied. We cover only those theoretical ap-
proaches operating with physical-chemical concepts relating to experi-
mental systems. This limitation gives, therefore, a selective view of the large
multidisciplinary field of excitable membrane r search. The major outcome
and interesting perspective is, however, the recognition that the rapid and
transient permeability changes in excitable membranes appear to reflect
special cases of a more general dissipative control principle that is based on
activator~receptor interactions.
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PHYSICAL CHEMISTRY OF EXCITABLE BIOMEMBRANES 119
ELECTROPHYSIOLOGICAL PROPERTIES
The electrical property particularly relevant for a mechanistic approach to
excitability is the electrical conductivity. This fundamental quantity can be
derived from voltage-clamp (VC) experiments where electric current relax-
ation is measured during (and after) a stepwise change in the voltage across
excitable membranes (1, 2). In connection with pharmacological methods
(application of activators and inhibitors) this technique has yielded evidence
that excitability generally involves two dominant, apparently independent
ion flows (3-9). The two current contributions are associated with opposite
ion gradients across apparently distinct pathways selective for certain ion
types (9, 10). These selective pathways (ion-transport channels) are proba-
bly spatially separated and have different kinetic properties (3, 4, 8, 9).
There is a rapid component usually carried by Na+ ions and a slower one
usually carried by K+ ions. Under depolarizing VC conditions the rapid
component is intrinsically transient, increases first, and then decreases,
whereas the slower contribution increases to a steady-state level (3-6). The
presence of Ca2+ ions appears to be essential for excitability (1, 2). 2+
ions interfere with Ca2+ action (11), suggesting that these ions do not just
participate in simple ion exchange that influences the surface potential but
probably are also coupled to structural properties of the membrane compo-
nents. The calculation of conductivity contribution g,. for an ion type i is
straightforward only when the ionic gradients do not change appreciably
during the VC experiment. This condition may be met only for short
clamping times.
Time Constants and Noise ~4nalysis
The VC technique is widely applied also to synaptic parts of excitable
membranes, and activators and inhibitors of the permeability control reac-
tions have been used as diagnostic tools. If the perturbations introduced by
voltage change and drug application are relatively small, the current relaxa-
tions can be described in terms of relaxation time constants. These funda-
mental experimental quantities in chemical systems are dependent on
environmental conditions of temperature, ionic composition, and ion con-
centrations (12). Furthermore, the time constants of axonal as well as 
synaptic parts of excitable membranes depend on the voltage across the
membrane (3-6, 13-17).
The analysis of fluctuation spectra of electric currents and voltage
changes in excitable membranes (channel noise) is in principle suited 
derive average pathway parameters, e.g. the lifetime of an open pathway
configuration (18, 19). However, mechanistic interpretations and numbers
have to be seen in the framework of the specified assumptions made before
analysis of the rather complicated noise spectra resulting from several
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120 NEUMANN & BERNHARDT
elementary processes. In a recent account, Neumcke concludes that the
selective gating of K÷ ions may involve transient binding of these ions to
the pathways (20).
The average lifetimes for the open configurations of synaptic pathways
controlled by acetylcholine (AcCh) in nicotinic receptor systems are about
1 msec (21, 22). Recent experiments by Stevens and co-workers show that
the time constants of the AcCh-induced productivity changes at neuromus-
cular receptor systems depend on the voltage across the postjunctional
membrane (13-17). The lifetimes of the open configurations induced 
AcCh binding are in the range of 1-10 msec.
Gating Concept
The measured time constants for the rapid conductivity changes in excit-
ability are in the msec time range and are associated with a temperature
coefficient of Ql0 ~" 2-3 (1). Time range and Ql0 together with the large
heat changes accompanying the action potential (23, 24) suggest that the
time course of the current relaxations cannot reflect simple electrodiffusion
(1) but is controlled by slower gating processes (3-6) in the ion pathways
of the membrane phase (25, 26).
If the conductivity changes in excitable membranes reflect rate-limiting
processes of the permeability changes, the time constants of the conduc-
tivity changes are equal to the time constants of the permeability control
system.
Recently, the so-called asymmetrical displacement-current contributions
in squid giant axons (27) and at frog Ranvier nodes (28, 29) have 
associated with intrinsic charge and dipole movements of a gating subunit
in the higher-order structure of the rapid pathway. The interpretation of
data on squid giant axon, for instance, is consistent with the assumed cubic
dependence of the Na+ conductivity contribution on specific subunits of the
Na+ gating system as proposed by Hodgkin & Huxley (3-6).
Due to lack of knowledge, mechanistic proposals for gating in axons are
usually chemically unspecific. The biochemical and analytical results on
excitable tissue of various origins led Naehmansohn to propose a chemically
specific model (30, 31). This proposal, at that time necessarily only qualita-
tive, is based on the activator-receptor concept that is now widely used for
synaptic control reactions. Nachmansohn suggested the acetylcholine sys-
tem as the general (dissipative) control device for the rapid regulation 
transient ion flows in bioelectricity (30-33).
Without doubt, the gating in axonal and synaptic parts of excitable
membranes involves membrane proteins, and the rate-limiting processes for
the conductivity changes are potential-dependent. Besides these common
properties there are many other similarities between axonal and synaptic
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PHYSICAL CHEMISTRY OF EXCITABLE BIOMEMBRANES 121
parts (25, 31, 32). There are, however, also a large number of electrical and
pharmacological differences. In particular, the failure of externally applied
tetrodotoxin to interfere with synaptic signal transmission and the failure
of externally applied a-bungarotoxin to interfere with nonsynaptic signal
conduction suggest differences. The differences by themselves are not sur-
prising: there are obviously morphological differences in the environment
of the excitable membranes of synaptic and axonal parts, probably provid-
ing different diffusion barriers for activators and inhibitors of the permeabil-
ity control systems. There are also action potentials, which are not blocked
by large doses of tetrodotoxin. At present, however, the mode of action of
the activators and inhibitors is unknown; none of the observed differences
is understood in molecular terms.
The phenomenological differences do not, therefore, necessarily indicate
differences in the control principle for the gating of passive iori flows.
Alternatively, different phenomena may be produced by structural and
organizational variations of one and the same regulatory principle, or even
control system. In particular, the synaptic parts of excitable membranes
appear to be coupled to additional reactions modifying a basic control
apparatus according to special requirements developed at later stages of cell
differentiation and evolution. Many so-called putative transmitters may
serve as modifiers of a general and unique control system (31). An integral
view of excitability operating with one control principle but allowing modi-
fications by additional factors has been outlined in a recent programmatic
study (33). This alternative requires one general assumption, whereas the
view of different mechanistic principles for each class of different electrical
and pharmacological phenomena requires a whole set of different assump-
tions.
GATING THEORIES
In a situation where only very little is known about the nature of the
observed phenomena, theoretical approaches are very useful as working
hypotheses. Model theories should cover the basic facts with a minimum
of complexity. Useful models must go beyond pure mathematical parametri-
zation and operate with physical-chemical quantities that can, at least in
part, be measured with independent methods (34).
Cooperativity
Many phenomena of excitation appear to reflect cooperativity. This cooper-
ativity can be an intrinsic property of the separated pathways or, alterna-
tively, may be caused by a cooperative coupling between the pathways. The
Hodgkin-Huxley formalism of nerve excitation reflects intrinsic channel
cooperativity (3-6). Tasaki proposes macromolecular cooperative transi-
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122 NEUMANN & BERNHARDT
tions coupled to ion exchanges in cooperative domain structures of the
membranes (2). The molecular theory of Adam operates with cooperative
pathway coupling through phase changes in the membranes (35). The
lattice theory developed by Blumenthal, Changeux & Lefever is also an
approach with inherent cooperativity in coupled membrane domains gating
passive ion flows (36). In a recent theoretical analysis Hill & Chert stressed
that there is no experimental evidence for cooperative channel coupling,
and that cooperativity is more likely an intrinsic pathway property (37, 38).
Cooperativity in dose-response curves does not necessarily reflect molecular
cooperativity in the activator-receptor interaction. In this context, a remark
of Magleby & Stevens (14) on the cooperative dose-depolarization response
curve published by Katz & Thesleff (39) is very instructive. If the depolari-
zations are recalculated to conductivity ratios, the conductivity-dose curve
shows no cooperativity (Hill coefficient of about 1). Thus, unless the
response parameter cannot be independently shown to reflect liganded
receptor in high permeability configurations, questions of molecular cooper-
ativity in terms of ligand binding cannot be answered. Values given for the
cooperative number of bound ligands for the elementary response must thus
be seen within the specific assumptions (sometimes physically unrealistic)
made to derive these values (16, 40, 41). Membrane-bound receptors show
signs of cooperativity, but no molecular details can be deduced unequivo-
cally (42, 43).
Theoretical Models
The majority of theoretical models for possible excitation mechanisms are
conservative. Since, however, permeability control systems in biological
membranes, like all biological regulatory devices, probably operate far from
equilibrium, dissipative elements appear to be necessary for an adequate
physical-chemical description of gating. Furthermore, the large heat
changes accompanying the nerve impulse suggest dissipation of free energy,
realized by "consumption of some substance." Thus, in particular the tran-
sient rapid conductivity component usually carried by Na÷ ions and respon-
sible for the "negative-resistance" feature (1) in excitable membranes
appears to be dissipatively gated by chemical means.
There is increasing evidence that two-state schemes using one open and
one closed configuration for the gating system are not sufficient to describe
newer VC data (44-48). On the next higher level of complexity are three-
state schemes. In a theoretical analysis, Jakobsson concluded that three-
state models are not superior to the Hodgkin-Huxley scheme, and that both
fail, even in the mathematical description of newer electrophysiological data
(48). It should, however, be recognized that this failure arises from a specific
ad hoc assumption appearing in connection with common procedures of
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PHYSICAL CHEMISTRY OF EXCITABLE BIOMEMBRANES 123
analyzing VC data. The schemes examined by Jakobsson and other propos-
als (3-6, 44-50) are applied together with the assumption that the func-
tional relationship between measured conductivity and intrinsic membrane
parameters is independent of membrane potential. If this restrictive as-
sumption is not made, there is at least one three-state model that accounts
for the newer VC results (51).
The time constants and amplitudes of current relaxations at constant
voltage for this model have recently been directly determined using a new
and simple analytic technique. If this method is applied, for example, to the
Na+-current component of axons, the functional relationship between
Na+ conductivity and the open configuration of the gating system is found
to be dependent on membrane potential. It could be shown that a dissipative
three-state model is able to reproduce all details of newer VC data including
the peak current ratio (h~) shift with test potential; no other model has 
far been able to accommodate the h~-shift.
CHEMICAL GATING PROCESSES
The acetylcholine receptor system represents the most intensively studied
gating system for ion flows in bioelectricity. For acetylcholine, the activa-
tor-receptor concept is clearly dissipative; the activator removal mechanism
is based on one of the fastest enzymes present in biological cells (30, 31, 52).
All mechanistic schemes proposed for the AcCh interaction with AcCh
receptor reflect the inherent assumption of competition between the acetyl-
choline esterase (AcChE) and receptor for AcCh (16, 30, 39, 43, 53). 
view of recent kinetic data on isolated AcCh receptor and AcChE, this
assumption appears doubtful. It was found that the association rate eon-
stant for the binding of cationic ligands, like N-methylacridinium or
quinolinium derivatives, is extremely high, ~-109 M-1 sec-1 (54). On the
other hand, for similar experimental conditions the association rate con-
stant of AcCh binding to isolated receptor proteins is only 3 X 107 M-1
sec-1 (55). So, binding of AcCh to AcChE is about 100 times more rapid
than the association of AcCh with the AcCh receptor. Even if substrate
inhibition of the esterase is considered, the competition hypothesis suggests
a very inefficient mechanism for the use of AcCh.
If, on the other hand, the reaction spaces for both proteins are spatially
separated, a sequential processing of AcCh can occur (25, 54). The reaction
space for the association of AcCh with the receptor may be the membrane
phase, whereas the hydrolytic removal may be extramembraneous. In this
hypothesis, the conformational transition of the receptor would not only
cause the permeability change but would also translocate AcCh to the
reaction space where AcChE hydrolyzes AcCh. Thus the permeability
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124 NEUMANN & BERNHARDT
increase is coupled to the flow of AcCh through the receptor to the esterase
(25, 31).
Control concepts for activators like AcCh express conductivity increase
in terms of AcCh bound to the high permeability configuration of receptors.
However, the binding step as such cannot be reflected in the conductivity
change because inhibitors bind too. Thus, some other process coupled to the
binding step must participate. The measured time constant of the conduc-
tivity change is then necessarily a normal-mode time constant of a coupled
reaction system (12). Now, depending on the coupling mechanism and the
"concentrations" of the reaction partners, the normal-mode time constant
may or may not be dependent on concentration. Thus the elucidation of
mechanistic details requires the measurement of concentration dependen-
cies. There may, however, be experimental conditions where the measured
time constant has dominant contributions from only one reaction step. Such
a situation may be reflected in the data of Stevens (16), who found opposite
potential dependencies for the effectiveness of neurally evoked and exter-
nally applied AcCh, respectively.
According to the AcCh flow scheme (Figure 1), nerve stimulation will
increase the AcCh concentration At in space 1 and drive the cycle along
the dominant reaction path AR ~ AR’. The closure process represented by
the transition R’-~ R will be independent of AcCh concentration, if the
concentration of AcCh, A(2), in reaction space 2 is kept low by esterase
activity. Thus nerve stimulation drives the AcCh cycle clockwise. On the
other hand, if external application of AcCh increases A(2), the opening
process is dominantly induced by the reaction A(2)+R’-~AR’; i.e. the AcCh
cycle is initially traversed counterclockwise. In this way, opposite potential
dependencies would be based on the respective dominance of opposite
pathways. If, in addition, receptor contributions to pharmacological desen-
sitization have to be incorporated, a third receptor state R" has to be
considered (Figure 1). The AcCh flow scheme is physically consistent with
the basic observations. It takes into account the "apparent inefficiency" of
AcCh binding to (isolated) receptor protein compared with AcChE. The
measured association rate constant for the AcCh binding to isolated recep-
tor from Torpedo californica (3 X 107 -1 sec-1) i s very c lose t o t he value
of 107 M-~ sec -1, derived by Sheridan & Lester from the concentration
dependence of the time constants measured at 3 mM Ba2+ in voltage-
clamped electroplax of Electrophorus electricus (17). The relatively low
value thus appears not to be a special property of isolated receptors in
solution. The kinetic data support the assumption that, as far as AcCh
effects are concerned, the isolated receptor protein retains functional integ-
rity when separated from the natural membrane environment.
An activator-receptor cycle like that in Figure 1 has been used to quanti-
tatively describe VC data of axons (51).
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PHYSICAL CHEMISTRY OF EXCITABLE BIOMEMBRANES 125
Neura( input ~ A(1)÷ [-~] ~ 
~
AcChe’sterase~’~- A(2)+ (~ ~ 
Figure 1 Reaction scheme for the in vivo translocation of acetylcholine (AcCh)
through the cholinergic receptor system. A(1), AcCh in reaction space 1 separated
from the acetylcholine esterase (AcChE); A~2), AcCh in reaction space 2 accessi-
ble to AcChE; R and AR, "nonconducting" states; R’ and AR’, high-perme-
ability configurations of AcCh receptor. Neural input drives the cycle along the
path R ~ AR ~ AR’; external application of AcCh populates AR’ also via
A(2) -k R’ --~ AR’.
The overall cyclic nature of a permeability control by AcCh in excitable
membranes is already indicated in a reaction proposal developed 25 years
ago (30). The present version of the acetylcholine cycle is shown in Figure
2, which displays the complexity of mutual coupling between the various
cycles directly or indirectly involved in rapid electrochemical permeability
control.
THE ACETYLCHOLINE RECEPTOR SYSTEM
A significant advance toward a more direct understanding of the molecular
nature of the AcCh receptor system was made in recent years. It became
possible to investigate membrane-bound and isolated receptor molecules by
biochemical and physical-chemical means (56-60).
Studies with receptor-rich membrane fragments have provided informa-
tion at an intermediate level of complexity between the in vivo system and
the isolated receptor material. On the one hand, the kinetic analysis of
tracer (22Na, 4°K) etilux measurements (61-64) appears to be a good alter-
native means of investigating ion conductance changes induced by activa-
tors. This technique has further allowed a more refined way of determining
classical pharmacological parameters. On the other hand, the study of the
binding properties of radioactively labelled or fluorescent ligands, in con-
junction with the similar studies performed with the isolated receptor, has
yielded valuable correlative information about the respective mechanisms
of action (65-68).
The methodological aspects of the procedures to isolate receptor proteins
have been reviewed in several recent articles (68-73). Here we focus 
examining the significance of the physical parameters that have been mea-
sured on the receptor material in various stages of preparation.
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126 NEUMANN & BERNHARDT
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Figure 2 Acetylcholine (AcCh) cycle of the dissipative chemical control of station-
ary membrane potentials, A~, and transient potential changes (and ionic cross-
membrane currents). The AcCh control cycle for the (rapidly operating) gateway
O (Ca2+ binding and closed) and O’ (the open permeative configuration) consists
of the AcCh receptor system (R), the AcCh esterase (E), the choline-O-acetyl-
transferase (ChT), and a (hypothetical) AcCh storage (S) system. The continuous
flux of AcCh through a R-E-ChT-S control "subunit" is maintained by ChT [cou-
pled to the choline (Ch+) uptake system], and by the practically irreversible hy-
drolytic removal of AcCh ion, A+, from the reaction space (~)by 
The opening-closing process O ~ G’ is controlled by the overall receptor reaction
R(Ca2+), + + ~(A+) R’+ n Ca2+, wit h n < ~ 2-3 . R i s the low, and R’ th e
high, conductivity configuration of the receptor. R" accounts for pharmacological
desensitization. In the resting steady state, the membrane potential (A@r) reflects
dynamic balance between the active transport (including AcCh-synthesis systems)
and the flux of AeCh through the control cycles surrounding the gateway. Fluctua-
tions in membrane potentials and ionic currents are amplified by fluctuations in the
local AcCh concentrations. The AeCh control cycle is probably coupled to tlae
electric field of the membrane by the receptor system. The encircled numbers refer
to different microreaction spaces for the processing of AcCh. This picture summa-
rizes the present knowledge and is a modified version of a former scheme [Neumann
& Nachmansohn (25, 32)].
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PHYSICAL CHEMISTRY OF EXCITABLE BIOMEMBRANES 127
So far the main sources for the extraction of the receptor material have
been homogenates of the electric organ of E. electricus and Torpedo species.
Although other receptor-rich preparations have been investigated (74-78),
the following discussion is limited to the AcCh-receptor system of Electro-
phorus and Torpedo, which have been studied more intensively. This recep-
tor appears to be an integral membrane protein (79). Detergent solutions
are required to isolate it from its membrane nvironment and to keep the
protein in solution. The essential step of virtually all purification procedures
presently used is the passage of a crude detergent extract through a suitably
labelled afffinity-chromatography column. The affinity-labelling compounds
used have either been a-neurotoxins or substances containing a quaternary
ammonium group.
Certain bulk physical-chemical properties of the receptor material have
been determined. Some of the measured values reflect that the intrinsic
properties of the isolated material vary according to the physiological origin
of the preparation (see Table 1). However, the amino acid composition 
Electrophorus and Torpedo receptors does not differ greatly from that of
other membrane-associated proteins (e.g. AcChE) (71, 72, 80). The isolated
material could be identified as a glycoprotein (63, 72). The isoelectric point
of various receptor preparations is in the range of 4.5 to 4.8 (81, 85),
indicating an effective negative charge at physiological pH values. It is
significant that the isolated receptor contains free SH groups (84, 86), which
appear to decrease upon storage. In the case of T. californica receptors, at
least 2 SH groups per AcCh-binding site were found (84).
The multiplicity of the values, particularly for AcCh equilibrium binding
constants and molecular weights, has led to a series of investigations partic-
ularly concerned with the possible modifications of the receptor protein
during extraction and purification.
Heterogeneity of Receptor Properties
Several measured properties of the receptor at various stages of preparation
and isolation have led to speculations about its functional role. The ability
Table 1 Summary of data on acetylcholine receptors
Bands in SDS-gel
Species electrophoresi~ Molecular weight Reference
Electrophorus 43,000; 48,000 -- 72
45,000; 54,000 230,000 -+ 15,000 124
T. californica 40,000; 50,000; 65,000 -- 68
-- 330,000; 660,000 97
T. marmorata 45,000; 50,000 -- 70
-- 330,000; 1,300,000 97
Annual Reviews
www.annualreviews.org/aronline
A
nn
u.
 R
ev
. B
io
ch
em
. 1
97
7.
46
:1
17
-1
41
. D
ow
nl
oa
de
d 
fro
m
 ar
jou
rna
ls.
an
nu
alr
ev
iew
s.o
rg
by
 D
eu
tsc
he
 F
or
sc
hu
ng
sg
em
ei
ns
ch
af
t o
n 
08
/0
6/
08
. F
or
 p
er
so
na
l u
se
 o
nl
y.
128 NEUMANN & BERNHARDT
to bind AcCh and other cholinergic activators has been used to characterize
the physical-chemical state of the protein, and changes in binding have been
associated with eonformational changes that may occur during receptor
functioning. Furthermore, the relative position of components in the sedi-
mentation profile of diverse receptor preparations has led to speculations
about the aggregation properties of receptor units and the role of possible
macroassociations of receptors necessary for excitability. The diversity in
ligand-binding parameters and colligative properties has been attributed to
a number of factors, such as the constraints present in the membrane and
the modifying effect of the solvent in solubilized and purified preparations.
As the values in Table 2 reflect, equilibrium binding measurements indi-
cate that the Torpedo membrane-bound receptor binds AcCh with a single
high-affinity constant corresponding to an equilibrium dissociation constant
K "" 10 nM, whereas solubilization and purification are associated with the
appearance of low-affinity binding sites, K "" 1 ~M.
O’Brien & Gibson (87, 88) have proposed that the low-affinity form is the
result of a denaturation of the high-affinity form, which is suggested to be
the physiologically significant state of the receptor. They found that the
membrane-bound receptor in fresh particulate fractions of T. californica
eleetroplax tissue is relatively insensitive to heat treatment. In contrast, in
the case of detergent extracts and purified receptor material, heating, aging,
or treatment with certain SH-group oxidizing agents leads to a predomi-
nantly low-affinity form. This irreversible conversion was suggested to in-
volve the oxidation of SH groups.
On the other hand, Sugiyama & Changeux (89) have reported that the
different binding forms are interconvertible. They found that dissolution of
receptor-rich fragments of Torpedo marmorata in cholate detergent led to
the appearance of medium-affinity (K ~- 0.1 /xM) and low-affinity AcCh-
binding sites. These forms were still present upon an exchange of detergents.
The dilution of the detergent solution was accompanied by a partial recov-
ery of the high-affinity binding sites. These results led Sugiyama & Chan-
geux to conclude that an intrinsic heterogeneity of the structure of the
receptor protein underlies the different binding forms, rather than deter-
gent-receptor interactions.
Since upon aging and purification of the receptor preparation no signifi-
cant recovery of high-affinity sites could be brought about (89), it is possible
that the low-affinity form observed by O’Brien & Gibson results from a
relatively severe treatment, and that the presumed interconvertible forms
of Sugiyama & Changeux are present under milder conditions.
Several authors have discussed the difference between the thermody-
namic dissociation constants (K) measured in binding studies for various
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Table 2 Acetylcholine-binding properties of acetylcholine receptor
129
Species Material K (M) Binding site Reference
T. marmorata membrane 1 × 10-8 -- 113
nmole/g tissue ,
T. marmorata homogenate 8 × 10-9 0.1 80
6.8 X 10-8 0.83
T. marmorata solubilized (crude) 1.4 X 10-9 0.2 ~ 81
2.2 x 10-8 0.45
T. marrnorata solubilized (crude) 2 × 10-8 0.5 84
T. marmorata solubilized (crude) 1.1 × 10-8 0.04 100
(1% Triton) 5.6 × 10-7 0.2
T. marmorata solubilized (crude) 4.2 × 10-9 0.087
(4% Lubrol) 3.3 × 10-7 0.15
% of toxin site
T. marmorata solubilized (crude) 1.7 × 10-7 40 89
1% Na-cholate 2 × 10-6 60
T. marmorata solubilized (crude)
2% Emulphogen 1.4 × 10-a 110
T. marmorata solubilized (crude) 1 × 10-8 57
5% Triton 3 × 10-7 43
T. marraorata solubilized (crude)
0.2-0.03% Triton 3 X 10-8 103
T. marmorata purified 3 × 10-8 6.8
2 × 10-6 107
T. marmorata & purified 2 × 10-8 34.6 84, 85
T. californica 2 × 10-6 65.4
T. californica membrane (fresh) 1.4 × 10-~ -- 87
T. californica solubilized (crude) 1.7 × 10-8 --
1% Triton
T. californica purified 2.3 × 10-6 42 83
T. californica purified 5 × 10-6 52 67
Electrophorus purified 6 × 10-8 46 72
receptor preparations and the half-response constants inferred from in vivo
electrophysiological or in vitro tracer-efflux binding studies. Since the half-
response constant is generally in the range of the K-values for the low-
affinity form, it has been proposed that the high-affinity form observed in
binding studies with membrane fragments is not associated with the physio-
logically active state of the receptor (66, 43). In accordance with models
proposed to explain pharmacological desensitization (39,90) Cohen et 
(66) suggested that, in addition to a "resting" and an "active" state, the
receptor can also exist in a "desensitized" form, which would have a high
affinity for activators.
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130 NEUMANN & BERNHARDT
Weber et al (91) have produced evidence in support of this hypothesis.
They found that the exposure of T. marmorata receptor-rich membrane
fragments to activators leads slowly (minute time range) and reversibly 
a 5- to 20-fold increase in affinity for activators. This property is lost after
aging of the preparations.
Popot et al (92) have reported that preincubation of T. marmorata
fragments with carbamylcholine causes a subsequent decrease of the ampli-
tude of the response to the same activator as measured by 22Na etitux.
Recently (3riJnhagen & Changeux (93) have used a fluorescent ligand, 
local anesthetic analog quinacrine, to investigate conformational changes of
the membrane-bound Torpedo receptor. They interpreted their results
within the framework of the model of Katz & Thesleff (39). A kinetically
unresolved rapid initial increase in fluorescence intensity upon the addition
of an activator is suggested to represent the activation of the receptor-
ionophore complex, while a subsequent slow decrease (second time range)
is thought to correspond to the generation of a desensitized state, exhibiting
a high affinity for activators.
Michaelson et al (94) have reported the presence of intereonvertible high-
and low-affinity binding forms in T. californica membrane fragments. They
suggested that the high-affinity form may correspond to a desensitized state,
and that conditions used for the preparation of membranes prior to affinity
chromatography in the isolation procedure could result in material largely
converted to that form irreversibly.
It appears, therefore, that activators induce a slow modification of the
membrane-bound receptor, which leads to a decrease of the electrophysio-
logical response, and an increase in the affinity for activators. A correspond-
ing effect has not been observed with solubilized or purified receptor
preparations (66). These findings may have the implication that only studies
with membrane-bound receptors will yield reliable information about the
functional properties of the physiologically active form of the receptor [see,
however, (17, 55)]. Furthermore, since several coupled kinetic steps appear
to be involved, equilibrium dialysis studies on conformational equilibria
yield only overall dissociation constants, which represent the ratio between
free ligand and total bound ligand.
It should be noted that while the studies cited above have dealt exclu-
sively with Torpedo material, relatively little has been reported concerning
desensitization in other preparations. Hess et al (95) have reported that
desensitization is not observed in efflux studies involving Electrophorus
membrane fragments.
An alternative but formally similar explanation of the difference between
the half-response constants and thermodynamic dissociation constants was
offered by O’Brien & Gibson (88). Noting that at sufficiently low AcCh
concentrations positive cooperativity is observed in equilibrium binding
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PHYSICAL CHEMISTRY OF EXCITABLE BIOMEMBRANES 131
studies, they proposed that the presence of two binding forms, of which only
one is physiologically active, could account for the observed data within the
framework of the Monod-Wyman-Changeux model (96).
A multiplicity of results has also been reported for the determination of
the molecular weight of various receptor preparations (see Table 1). Chang
(86) found that the relative number of components with a molecular weight
higher than the main species observed in gel electrophoresis and gel exclu-
sion chromatography increase during storage of the purified Electrophorus
receptor, and proposed that an irreversible aggregation of the major compo-
nent was caused by an oxidation process leading to the formation of inter-
molecular disulfide linkages. Edelstein et al (97) found that aside from 
330,000-dalton unit, T. marmorata preparations contain a 1,300,000-dalton
unit, and T. californica preparations a 660,000-dalton unit. They also sug-
gest that the heavier components may result from SH-group oxidation
during storage. In this connection it is noteworthy that commercially avail-
able detergents often contain oxidizing agents as contaminants or bleaching
materials that might promote the aggregation of solubilized receptor (98).
O’Brien and co-workers (88, 99) investigated the sedimentation profile 
solubilized and purified Torpedo receptor preparations. Their results for
T. californica protein indicate that a low-molecular-weight (L) form and 
relatively heavier form (H) figure prominently. Heating had no effect on the
L form but halved the peak for H, and led to the appearance of a heavy
oligomer (HH). Similarly at high pH, the L peak was left unaltered but the
H peak was again decreased, and a low-molecular-weight component (LL)
was formed. Both H and L peaks were found to be stable at neutral pH.
The authors proposed a tentative assignment of molecular weights, where
the LL form is suggested to be a minimal binding unit (89,000 daltons), and
the H form was identified as a dimer of the L form and a hexamer of the
LL form. The HH form was interpreted to be a detergent artifact. The H
form is considered a likely candidate for the physiologically active unit.
It appears that our present knowledge of the physical state of the receptor
macromolecules in various preparations is marred by the possibility of
artifacts associated with the presence of detergent, oxidizing contaminants
in the detergent, and the absence of membrane constraints required to
maintain a physiologically active configuration. Much careful work will be
required to assure that the evidently quite labile protein is obtained in a
functionally intact form, so that physiologically more relevant physical-
chemical studies can be carried out.
Ligand Binding and Receptor Functioning
As was discussed above, in vivo investigations have revealed that a relatively
complex chain of processes is involved that leads to the conductance
changes induced by the binding of activators. Desensitization, cooperative
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132 NEUMANN & BERNHARDT
effects, the "control" properties of Ca2+ ions, the influence of the membrane
potential, and the selectivity in the transfer of ions should all be accounted
for in a full description of receptor functioning. Although at present our
knowledge is still very incomplete, ligand-binding studies, and studies in-
volving the chemical modification of the receptor, have yielded some infor-
mation about the nature and disposition of receptor groups that take part
in the molecular events underlying permeability changes.
Pharmacological investigations have shown that the AcCh receptors of
eel and Torpedo electric organs have ligand-binding properties typical of
nicotinic cholinergic receptors (82, 100, 101). There have been several
attempts to deduce the nature of the nicotinic agonist-binding region (102-
105). The site complementary to most monoquaternary nitrogen activators
presumably contains an anionic moiety corresponding to the quaternary
nitrogen groups, and a spatially restricted region capable of accommodating
a relatively flat group, such as an aromatic ring or a carbonyl segment (106).
Furthermore, it is probable that there is a proton donor group at the
receptor complementary to the AcCh carbonyl oxygen (107).
Little is known about the intramolecular processes in the receptor that
are connected with activator binding. However, since the tetramethylam-
monium ion itself is an activating ligand (108), an interaction involving the
anionic binding site appears to be of fundamental importance. Whether
further interactions with the nonquaternary portion of activators serve to
promote conformational transitions triggered by binding, or whether they
merely prolong the lifetime of the activator-receptor complex, remains to
be determined.
Karlin et al have studied changes in receptor properties brought about
by selected chemical modifications. They found that the reduction of at least
one disulfide bond in the Electrophorus electroplax receptor leads to a
change in the pharmacological specificity. The in vivo response to mono-
quaternary activators is decreased (109), and the response to bisquaternary
agents is increased (108). Studies involving the covalent attachment 
affinity-labelling compounds (108, 110) to the reduced receptor have led 
conclusions about the spatial position of the labile disulfide bond relative
to the anionic binding site. It has been suggested that the receptor-activator
binding compartment in the active state is in a "shortened" conformation
compared to that in the inactive state (111).
A number of investigations have revealed the existence of apparently
distinct binding sites for several other low-molecular-weight ligands. Phar-
macological studies indicate that local anesthetics such as procaine and
tetracaine bind at a site that interacts noncompetitively with the monoquat-
ernary activator-binding site (112-114). Cohen et al studied the effect 
various local anesthetics on the binding of AcCh and the fluorescent ligand
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PHYSICAL CHEMISTRY OF EXCITABLE BIOMEMBRANES 133
dansylcholine to the membrane-bound Torpedo receptor (66). They found
that these agents increase the affinity of the receptor for both cholinergic
activators and inhibitors at about the same concentrations at which they are
physiologically active.
Investigations of the competition of mono- and bisquaternary agents with
the binding of the fluorescent ligand bis-(3-aminopyridinum) 1,10-decane
diiodide to the purified T. californica receptor led Raftery et al (68) to 
model for ligand binding that encompasses two anioniesites. Monoquater-
nary activators are thought to bind to one of the two subsites, while the
other would preferentially complex inorganic ions. Bisquaternary agents
are considered to be bound to both moieties and to interact competitively
with the binding of monoquaternary agents at one site.and with the binding
of cations at the other. It should be noted, however, that the apparent
binding properties of charged ligands are intrinsically dependent on the
ionic strength of the solution. Changes in the apparent binding constants
caused by direct competition with inorganic cations may therefore not be
a necessary assumption.
It is not known how the auxiliary binding sites of the receptor system for
bisquaternary compounds or local anesthetics are involved in the in vivo
receptor functionings.
There have been several investigations of the binding of divalent cations
to the receptor purified from Torpedo electric organs (25, 68, 115-117).
Eldefrawi et al found that large amounts of calcium ions are bound to the
receptor (115). They reported that 2+ can block the bi nding of[3H]acetyl-
choline, and deduced an apparent dissociation constant of 7 X 10-3 M for
this cation. Riibsamen et al (117) studied the fluorescence enhancement that
accompanies the binding of terbium ions to the receptor. Assuming a direct
competition between Ca2+ and Tb 3+ ions, they obtained an apparent dis-
sociation constant of 1.1 _ 0.1 mM for Caz+. Their results further indicate
that Tb3+ ions, bound to sites that interact with Ca2+ ions, are displaced
by activators, but not by inhibitors.
Riibsamen et al (118) have also proposed that the terbium-binding sites
of the receptor are associated with the same polypeptide chain as the
binding site for activators. However, it may be questioned whether the
binding sites they report for receptor fragments under denaturing condi-
tions (SDS treatment) are to be identified with sites present in the intact
material.
Chang & Neumann (25, 55, 116) studied the calcium-binding properties
of Electrophorus and Torpedo receptors by a number of methods. In the
case of Torpedo californica receptors there are at least three types of binding
sites with apparent dissociation constants ranging from mM to </.tM. The
results indicate that at least one of these sites is competitively affected by
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134 NEUMANN & BERNHARDT
the binding ofAcCh (Kc~ = 3 X 10-3 M). In agreement with the dependence
of the apparent AcCh dissociation constant on Ca2+ concentration, it was
found that AcCh binding leads to a release of Ca2+ ions from the receptor.
On the other hand, a-bungarotoxin causes an uptake of Ca2+ ions. It thus
appears that neural activators and inhibitors have opposing effects on the
Ca2+ binding of receptors (116).
In contrast to these findings for the purified receptor, Cohen et al (66)
reported that receptor-rich Torpedo membrane fragments show increased
affinity for cholinergic ligands in the presence of Ca2+. This effect, which
was not observed with detergent-solubilized Ol~ purified preparations (66),
was suggested to be related to the increase in desensitization brought about
by Ca2+ ions in electrophysiological studies in vivo (43, 66).
These findings indicate that the functionally significant ligand interac-
tions with the intact receptor units are relatively complex. There is at
present little information about the detailed molecular events that are elic-
ited or controlled by the binding of Ca2+ ions. According to specific propos-
als (31-33) the binding of AcCh was suggested to lead to a release 
Ca2+ ions that is concomitant with a change in structure and organization
of the gateway controlling the permeability to passive ion fluxes. Indeed,
recent kinetic results show that the Ca2+-receptor interactions involve at
least three conformational states and that there is at least one intramolecu-
lar (conformational) change in the isolated receptor upon AcCh binding
(55). Thus the receptor activation would be inhibited by 2+ ions, whereas
the process observed by Cohen et al, attributed to physiological desensitiza-
tion, is favored by Ca2+ ions (39, 66).
At present little is known about a possible coupling of receptor sites to
the membrane potential. However, the voltage dependence of conductance
changes implies that such a coupling exists. This coupling could involve
orientations of poly-ionic regions or dipoles of the receptor, in the trans-
membrane lectrical field, or it may be indirectly connected with the coun-
terion atmosphere associated with fixed charges, or the binding equilibrium
itself may be dependent on the electrical field.
Structural Organization and Functional Role
of Receptor Subunits
Since the intact receptor-ion translocation system must ultimately include
a membrane-partitioned structure across which ionic gradients are main-
tained, certain functional properties of the native control system will neces-
sarily not be measurable on the isolated receptor material. This absence of
intrinsic properties clearly limits the possibility of examining the degree to
which the isolation procedure modifies the receptor unit. Although the
presence of a component responsible for the recognition of characteristic
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PHYSICAL CHEMISTRY OF EXCITABLE BIOMEMBRANES 135
ligands is virtually assured, since ligand binding can be used to register the
success of the extraction procedure, components associated with the ion-
translocation process may have been lost or modified. Obviously the recon-
stitution of the isolated materials in a membrane is required to investigate
the full spectrum of functional properties observed in the in vivo system.
The investigation of receptor material using gel electrophoresis under
denaturing conditions has indicated the presence of several possible subu-
nits (see Table 1) in which a 40,000-dalton unit and a slightly heavier unit
of 54,000 daltons figure prominently.
The structural organization of isolated receptor and of receptors in mem-
branes has been studied by a number of techniques. Electron micrographs
of purified Electrophorus (72) and Torpedo (71) receptors indicate the
presence of ring-like particles, 8-9 nm in diameter, which appear to consist
of 5-6 subunits surrounding an electron-dense core. Freeze-etching (119,
120) and negative-staining (121) electron micrographs, as well as X-ray
diffraction studies (122, 123) of receptor-rich Torpedo membranes, reveal
a closely packed, regular array of particles, with a diameter of approxi-
mately 8 nm.
These findings have stimulated the proposals of specific models for the
organization of receptor subunits in membranes. Huclao & Changeux (124)
have suggested that three possibly identical subunits may be involved in the
binding of cholinergic ligands, while other different subunits coupled to
these may be involved in ion-transport processes. Raftery et al (123) have
proposed a model encompassing three pairs of subunits organized in layers,
which would have an inherent structural asymmetry.
The presence of a unit associated with the transport of ions (ionophore)
in isolated preparations, which is functionally coupled to the activator-
binding region of the receptor, is strongly indicated by reconstitution ex-
periments utilizing receptor-rich membrane fragments. Hazelbauer &
Changeux (125) were able to show that solubilization of microsacs in cho-
late, and subsequent reconstitution in a membrane of crude lipids extracted
from the native membranes, does not entail a loss of agonist-induced cation
permeability properties. Michaelson & Raftery (94, 126) incorporated puri-
fied receptor material into vesicles made from extracted Torpedo lipids.
They were able to show that these structures were in several cases excitable
by acetylcholine and carbamylcholine.
Attempts to incorporate receptor material in black lipid films have been
reported by several laboratories (127-131). It appears that the technique 
very susceptible to artifacts. Experience has shown that minute amounts of
bacteria, organic impurities, and dust particles can cause major electrical
artifacts. The quantities that have been determined are the rate of conduc-
tance increase and miniature conductance changes.
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136 NEUMANN & BERNHARDT
AN INTEGRAL VIEW OF RECEPTOR-MEDIATED
ELECTRICAL CHANGES
Receptor-activator interactions control the production of a physiological
response in numerous systems. A common feature of receptor-mediated
processes is that the binding of a specific ligand ~,o the receptor leads to the
activation of a further functional component, the effector.
Cuatrecasas and co-workers (132-135) have proposed the mobile recep-
tor model as a mechanistic scheme whereby hormone receptor occupancy
generates biological signals. Hormone receptors and effectors are thought
to diffuse independently within the plane of the membrane. The receptor
may associate reversibly with the effector to regulate its activity. The affinity
of the hormone-receptor complex for effector is suggested to be greater than
the affinity of the unoccupied receptor for the effector.
A general scheme for signal-transmitting processes has recently been
proposed by Strange & Koshland (136). Receptors are designed to bind
specific ligands with high affinity, to ensure sensitivity at low concentrations
of ligand. Either the receptor may be structurally closely connected with the
effector part, or it may associate with the effector system only after activator
binding. In a complex system comprising several receptor macromolecules,
each receptor may interact with a different effector ("parallel pathway"),
or receptors may compete for an effector ("focused pathway"). In excitable
membranes receptors are functionally coupled with effector units, control-
ling the membrane permeability to ions. The effector need not be a molecu-
lar entity separate from the receptor macromolecule, but it must comprise
a functional component assuring a lower activation barrier for transmem-
brane ion transfer than that of the remaining membrane phase.
The electrical responses induced by neural activators at synapses and
neuromuscular junctions may be classified according to their time course
and the nature of the electrical polarization generated. Thus, at mammalian
ganglionic synapses a fast excitatory postsynaptic potential (f-e.p.s.p.), 
slow excitatory postsynaptic potential (s-e.p.s.p.), and a slow inhibitory
postsynaptic potential (s-i.p.s.p.) have been discerned. The f.-e.p.s.p, occurs
within milliseconds, and is elicited by the interaction of AcCh with nicotinic
cholinergic receptors. The s-e.p.s.p, is due to the AcCh-induced activation
of muscarinic cholinergic receptor systems and has a minimum latency of
"-100 msec and a duration of 0.5 sec or longer (137-139). The s-i.p.s.p, 
elicited by dopamine. Evidence is accumulating that the dopaminergic re-
sponse is mediated by the production of cyclic AMP, by an adenylate cylase
coupled to the dopamine receptor (140-144). It has been proposed that the
physiological response is ultimately produced by the phosphorylation of a
membrane protein through the agency of protein kinases (144). Similarly
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PHYSICAL CHEMISTRY OF EXCITABLE BIOMEMBRANES 137
there is evidence that the muscarinic response is mediated by cyclic GMP
(142, 143, 145, 146) and that muscarinic cholinergic receptors are coupled
to a guanylate ¢yclase.
Purves (147) has proposed that muscarinic receptors are specialized 
allow efficient temporal summation of potential changes. On the other hand,
the rapid responses controlled by nicotinic receptors are less suited for
mutual summation. They operate with a shorter latency and a correspond-
ingly greater temporal precision. It appears that systems involving produc-
.tion of a cyclic-nucleotide-mediated response may generally be associated
with a relatively slow rate of onset. Their functional role in connection with
nicotinic action is to "regulate" the potential across the synaptic membrane,
and thereby to modulate nicotinic cholinergic processes.
The investigation of the cholinergic receptors of fish electric organs has
not led to unequivocal evidence that the ion-translocation (effector) compo-
nent is a part of the receptor macromolecule, although reconstitution stud-
ies with microsacs suggest this alternative. The rapid response of the
nicotinic system to activators would therefore be attributable to the direct
functional association of the activator-receptive unit with the effector com-
ponent.
Another factor that may be connected with the special role of the nico-
tinic system is the relative lack of specificity of activator-nicotinic receptor
interactions. Pharmacological studies indicate that the muscarinic activa-
tor-binding site is spatially much more restricted than the corresponding
nicotinic site. The degree to which modifications of the chemical structure
of the muscarinic activator affect pharmacological activity is correspond-
ingly greater (107, 148). In the case of activators of the fl-adrenergic recep-
tors it appears that a certain portion of the activator functional groups are
connected with the affinity of these agents, while another portion primarily
determines the response-producing capacity (149).
The lack of this type of specificity at nicotinic activator sites may "be
connected with the kinetic steps required to produce a rapid response, e.g.
rapid access to and departure from the binding region for activators.
Jencks (150) has recently discussed at length how the intrinsic binding
energy that results from the noncovalent interaction of a specific substrate
with the active site of an enzyme may be utilized to provide the driving force
for the catalytic modification of the substrate molecule. In the case of
receptor-activator interactions, the situation is somewhat reversed. The
activator molecule A has the "catalytic" function of reducing the activa-
tion barrier for a transition to an altered form R’ of the receptor mole-
cule R. The intrinsic binding energy of the activator is therefore utilized
to promote the population of a specific receptor form AR’. This process
may predominantly occur either by means of an induced change via
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A + R ~ AR ~ AR’ (upper pathway), or by means of a shift in the
equilibrium involving the less populated form of the receptor R’ (lower
pathway) via A + (R’ ~ R) ~ AR’:
A+R~; AR
A + R’ ~ AR’
Such a cyclic kinetic scheme adequately expresses essential features of the
activation phase of activator-receptor interactions. In addition, a mecha-
nism responsible for the removal of activator from the reaction compart-
ment contributes to the overall dissipative nature of these processes.
Although many hormone-receptor complexes are associated with a rela-
tively long period of action, rapid removal of activator by a degradative
protein such as AcChE, or by reuptake of activator, occurs in synaptic
control processes. The same general activator-receptor mechanism can be
used to describe quantitatively the rapid transient permeability changes in
nonsynaptic (axonal) parts of excitable membranes. Such a regulatory prin-
ciple, entailing fast dissipative changes, appears to be a distinguishing fea-
ture of electrical-chemical excitability. The functional significance of this
special case of activator-receptor interaction is presumably to ensure fast
repetitive responses of the receptor system in excitable membranes, by the
rapid regeneration of active receptive units.
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